Amgen Inc.

NASDAQ:AMGN

Drug Manufacturers - General

Healthcare
$443.89 -2.03%

-$6.93 today

Market cap
$240.11B
Beta
0.42
P/E (TTM)
23.2
EPS (TTM)
$14.44
Dividend yield
2.93%
52W Low $267.83High $391.29

Volume 2.58M

Average 2.76M

AMGN Pre-Tax Margin

Income before tax as a percentage of revenue.

Amgen Inc.NASDAQ: AMGN

Pre-Tax Margin · Q2 FY2026 · quarter ended Jun 2026

Pre-tax margin widens to 27.5%

Pre-tax margin was 27.5% in Q2 FY2026, up 10.4 pp from a year earlier. On a trailing-twelve-month basis it was 27.0%, up 5.7 pp year over year. Over 3 fiscal years it narrowed by 3.5 pp.

Context

  • Pre-tax margin widened in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
27.5%+3.3 pp QoQ
Last fiscal yearDec 2025
24.4%+10.6 pp YoY
LTMJun 2026
27.0%+5.7 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+10.4 pp——
1 year+10.6 pp——
3 years-3.5 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
24.4%
Year-over-year change
+10.6pp

Pre-Tax Margin vs competitors

How AMGN compares with its peers on the latest reported figures

  • AMGN's LTM Jun 2026 pre-tax margin of 27.0% is the 3rd highest of the 10 companies compared; the peer median is 19.4%.
  • Its year-over-year change of +5.7 pp is the 4th highest of 10, against a peer median of +1.6 pp.
  • Over three fiscal years its change of -3.5 pp compares with a peer median of +4.7 pp.
AMGN Competitors Peer median
Pre-Tax Margin for AMGN and competitors
Company Period LTM level YoY 3-year change
LLYEli Lilly and CompanyLTM Jun 202642.2% +10.5 pp+15.6 pp
NVSNovartis AGLTM Jun 202627.9% -0.4 pp+13.5 pp
AMGNAmgen Inc.LTM Jun 202627.0% +5.7 pp-3.5 pp
BMYBristol-Myers Squibb CompanyLTM Jun 202624.2% +10.4 pp+2.6 pp
AZNAstraZeneca PLCLTM Sep 202621.3% +1.6 pp+15.5 pp
ABBVAbbVie Inc.LTM Sep 202619.4% +16.6 pp-12.4 pp
JNJJohnson & JohnsonLTM Sep 202617.9% -16.3 pp+10.4 pp
GSKGSK plcLTM Jun 202617.8% +3.2 pp+3.5 pp
MRKMerck & Co., Inc.LTM Jun 20269.0% -21.1 pp+4.7 pp
PFEPfizer Inc.LTM Jun 20266.6% -9.9 pp-22.3 pp
Peer median (excluding AMGN) 19.4%+1.6 pp+4.7 pp

Competitors are the stored peer set for AMGN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue25.98B26.32B28.19B33.42B36.74B
Cost of Revenue6.45B6.41B8.42B12.86B10.73B
Gross Profit19.53B19.92B19.78B20.57B26.01B
Gross Margin75.2%75.7%70.1%61.5%70.8%
Research & Development6.32B4.43B4.78B5.96B6.97B
Selling, General & Admin5.37B5.41B6.18B7.1B7.05B
Operating Expenses11.89B10.35B11.84B13.31B15.34B
Depreciation & Amortization3.4B3.42B4.07B5.59B5.17B
EBITDA11.3B12.17B14.8B13.36B16.9B
EBITDA Margin43.5%46.2%52.5%40.0%46.0%
Operating Income7.64B9.57B7.9B7.26B10.68B
Operating Margin29.4%36.3%28.0%21.7%29.1%
Interest Income00000
Interest Expense1.2B1.41B2.88B3.16B2.76B
Other Income / Expenses(938M)(2.22B)(42M)(2.65B)(1.7B)
Income Before Tax6.7B7.35B7.86B4.61B8.98B
Pre-Tax Margin25.8%27.9%27.9%13.8%24.4%
Income Tax Expense808M794M1.14B519M1.27B
Net Income5.89B6.55B6.72B4.09B7.71B
Net Margin22.7%24.9%23.8%12.2%21.0%
EPS (Basic)10.3412.1812.567.6214.33
EPS (Diluted)10.2812.1112.497.5614.23
Weighted Avg Shares570M538M535M541M538M
Weighted Avg Shares (Diluted)573M541M538M541M542M

Amgen Inc.

NASDAQ:AMGN

Intrinsic Alpha fair value

Locked

Current Price

$443.89

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.